Skip to content

CBLL

CeriBell, Inc.

NASDAQ · USHealthcareMedical - Devices
$18.43-1.55%

Price as of Jul 20, 2026

CBLL news

CeriBell, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026

    SUNNYVALE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for the second quarter of 2026 after the close of trading on Monday, August 10, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on August 10,

    Globe Newswire ·

  2. Ceribell Reports First Quarter 2026 Financial Results

    SUNNYVALE, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 & Recent Highlights * Reported total revenue of $26.5 million in the first quarter of 2026, a 29% increase compared to the same period in 2025 * Ended the quarter with 680 tot

    Globe Newswire ·